A new trading day began on Monday, with Ideaya Biosciences Inc (NASDAQ: IDYA) stock price up 10.93% from the previous day of trading, before settling in for the closing price of $29.18. IDYA’s price has ranged from $13.45 to $32.67 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -0.01% over the past five years. Meanwhile, its annual earnings per share averaged -0.52%. With a float of $80.64 million, this company’s outstanding shares have now reached $87.64 million.
Ideaya Biosciences Inc (IDYA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Ideaya Biosciences Inc is 8.00%, while institutional ownership is 104.13%.
Ideaya Biosciences Inc (IDYA) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.6 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.87 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.46% during the next five years compared to -0.01% drop over the previous five years of trading.
Ideaya Biosciences Inc (NASDAQ: IDYA) Trading Performance Indicators
Here are Ideaya Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 12.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 405.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.79, a number that is poised to hit -0.83 in the next quarter and is forecasted to reach -3.36 in one year’s time.
Technical Analysis of Ideaya Biosciences Inc (IDYA)
Ideaya Biosciences Inc (NASDAQ: IDYA) saw its 5-day average volume 1.27 million, a positive change from its year-to-date volume of 1.18 million. As of the previous 9 days, the stock’s Stochastic %D was 67.78%.
During the past 100 days, Ideaya Biosciences Inc’s (IDYA) raw stochastic average was set at 99.33%, which indicates a significant increase from 98.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.64 in the past 14 days, which was higher than the 1.16 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $26.35, while its 200-day Moving Average is $22.11. Nevertheless, the first resistance level for the watch stands at $33.52 in the near term. At $34.68, the stock is likely to face the second major resistance level. The third major resistance level sits at $36.90. If the price goes on to break the first support level at $30.14, it is likely to go to the next support level at $27.92. The third support level lies at $26.76 if the price breaches the second support level.
Ideaya Biosciences Inc (NASDAQ: IDYA) Key Stats
With a market capitalization of 2.84 billion, the company has a total of 87,644K Shares Outstanding. Currently, annual sales are 7,000 K while annual income is -274,480 K. The company’s previous quarter sales were 0 K while its latest quarter income was -72,180 K.
